KinDex Pharmaceuticals Company

KinDex Pharmaceuticals is a developer of novel therapeutics used to help patients suffering from metabolic disorders.

Investors

Industry: Longevity
Headquarters: Seattle, Washington, United States
Founded Date: 2009-01-01
Funding Status: Early Stage Venture
Total Funding: $5 827 274
Estimated Revenue: Less than $1M
Last Funding Date: 2016-08-30
Last Funding Type: Debt Financing
Visit Website
https://twitter.com/kindexpharma
Register and Claim Ownership